iA Global Asset Management’s Terns Pharmaceuticals TERN Stock Holding History

iA Global Asset Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,073	Closed	-$57K	–	509
2026 Q1	$57K	Hold	1,073	–	–	﹤0.01%	384
2025 Q4	$43K	Buy	+1,073	New	+$24.8K	﹤0.01%	384

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

iA Global Asset Management's TERN Position: Q2 2026 in Review

iA Global Asset Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 1,073 shares — an estimated $57K sold.

iA Global Asset Management first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $57K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

iA Global Asset Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
iA Global Asset Management sold 1,073 Terns Pharmaceuticals shares in Q2 2026, an estimated $57K.
iA Global Asset Management first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
iA Global Asset Management's Terns Pharmaceuticals position peaked at $57K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on iA Global Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.